Published in Surgery Litigation and Law Weekly, September 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at OraSure Technologies, Inc.
Report 1: OraSure Technologies, Inc. (NASDAQ:OSUR), the market leader in oral fluid diagnostics, announced pre-clinical study results for a prototype rapid Hepatitis C ("HCV") antibody test on the Company's OraQuick(R) test platform, using oral fluid, finger-stick whole blood, venous whole blood, serum and plasma samples. These results were reported by OraSure at the 2007 Annual Meeting of the American Association of Clinical Chemistry held in San Diego,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.